Alector Inc (ALEC)
5.335
+0.16
(+2.99%)
USD |
NASDAQ |
Apr 23, 16:00
5.335
0.00 (0.00%)
After-Hours: 20:00
Alector Cash from Financing (TTM): 2.55M for Dec. 31, 2023
Cash from Financing (TTM) Chart
Historical Cash from Financing (TTM) Data
Date | Value |
---|---|
December 31, 2023 | 2.55M |
September 30, 2023 | 2.596M |
June 30, 2023 | 3.085M |
March 31, 2023 | 3.11M |
December 31, 2022 | 4.514M |
September 30, 2022 | 12.52M |
June 30, 2022 | 26.85M |
March 31, 2022 | 28.90M |
December 31, 2021 | 30.30M |
September 30, 2021 | 22.75M |
June 30, 2021 | 8.218M |
Date | Value |
---|---|
March 31, 2021 | 7.526M |
December 31, 2020 | 232.11M |
September 30, 2020 | 232.45M |
June 30, 2020 | 232.89M |
March 31, 2020 | 230.50M |
December 31, 2019 | 172.35M |
September 30, 2019 | 169.64M |
June 30, 2019 | 231.25M |
March 31, 2019 | 301.52M |
December 31, 2018 | 131.15M |
Cash From Financing Definition
Cash flow from financing is a major line item of the statement of cash flows. This metric tracks the movement of cash flows for the overall financing activities of the company. A few examples of financing activities include common stock issuance, total dividends paid, and net debt issuance.
Cash from Financing (TTM) Range, Past 5 Years
2.55M
Minimum
Dec 2023
232.89M
Maximum
Jun 2020
87.06M
Average
26.85M
Median
Jun 2022
Cash from Financing (TTM) Benchmarks
AbbVie Inc | -17.22B |
Reviva Pharmaceuticals Holdings Inc | 33.17M |
NovaBay Pharmaceuticals Inc | 1.91M |
Palatin Technologies Inc | 5.553M |
iBio Inc | 10.68M |